Skip to main content

Alpine Immune Sciences, Inc.

ALPNDelisted May 20, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001626199

Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Alpine Immune Sciences, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ALPN: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders4453+9
Shares15.3M18.6M+3.24M (+21.1%)
Value$163.5M$257.1M+$93.6M (+57.2%)

New holders (13)

Institutions that held Alpine Immune Sciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ALPN in Q4 2021
InstitutionSharesValue% of portfolio
Lynx1 Capital Management LP1,261,927$17.5M15.25%
TCG Crossover Management, LLC1,170,212$16.2M7.59%
Acuta Capital Partners, LLC230,000$3.19M1.34%
Walleye Capital LLC110,099$1.52M0.05%
Westwood Holdings Group Inc.23,079$319.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.19,026$264.0K0.00%
Goldman Sachs Group Inc13,379$185.0K0.00%
Jump Financial, LLC12,600$175.0K0.01%
Western Wealth Management, LLC12,360$171.0K0.02%
Parametric Portfolio Associates LLC10,875$151.0K0.00%
Allspring Global Investments Holdings, LLC6,027$83.0K0.00%
STRS Ohio5,500$76.0K0.00%
Daiwa Securities Group Inc.85$1.00K0.00%

Sold out (4)

Institutions that held Alpine Immune Sciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ALPN in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
DAFNA Capital Management LLC111,501$1.19M
Leonard Rickey Investment Advisors P.L.L.C.17,013$182.0K
HighVista Strategies LLC14,268$152.0K
EcoR1 Capital, LLC7,001$75.0K